April 20, 2024
Market Now
Samsung BioLogics' Q1 operating profit W3.4b
[DISCLOSURE] Samsung BioLogics (207940) reported on April 25 that its operating profit came in at 3.40 billion won (US$3.03 million) turning to black from the same period last year.
Its revenue rose 21.3 percent on-year to 107.65 billion won while net loss reached 33.07 billion won.
By Hwang You-mee (theinvestor@heraldcorp.com)
Its revenue rose 21.3 percent on-year to 107.65 billion won while net loss reached 33.07 billion won.
By Hwang You-mee (theinvestor@heraldcorp.com)
